Detalles de la búsqueda
1.
A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response.
Clin Infect Dis
; 2024 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38305378
2.
Comparison of Clostridioides difficile nucleic acid amplification test (NAAT) results using fresh and frozen stool specimens and rectal swabs.
J Clin Microbiol
; 62(1): e0103723, 2024 01 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38078766
3.
Costs Attributable to Clostridioides difficile Infection Based on the Setting of Onset.
Clin Infect Dis
; 76(5): 809-815, 2023 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36285546
4.
The Impact of Universal Glove and Gown Use on Clostridioides Difficile Acquisition: A Cluster-Randomized Trial.
Clin Infect Dis
; 76(3): e1202-e1207, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35776131
5.
Walk before you run: Feasibility challenges and lessons learned from the PROCLAIM study, a multicenter randomized controlled trial of misoprostol for prevention of recurrent Clostridioides difficile during COVID-19.
Anaerobe
; 80: 102699, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36702174
6.
Can prediction scores be used to identify patients at risk of Clostridioides difficile infection?
Curr Opin Gastroenterol
; 38(1): 7-14, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34628418
7.
Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial.
BMC Infect Dis
; 22(1): 245, 2022 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35279084
8.
Epidemiology of Left Ventricular Assist Device Infections: Findings From a Large Nonregistry Cohort.
Clin Infect Dis
; 72(2): 190-197, 2021 01 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31925953
9.
Oral Vancomycin as Secondary Prophylaxis for Prevention of Recurrent Clostridioides difficile Infection.
N Engl J Med
; 388(7): 654-656, 2023 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36791167
10.
The role of chronic suppressive antibiotics therapy in superficial drive line infection relapse of left ventricular assist devices: A retrospective cohort from a tertiary care center.
Transpl Infect Dis
; 23(4): e13686, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34251073
11.
Comparing intervention strategies for reducing Clostridioides difficile transmission in acute healthcare settings: an agent-based modeling study.
BMC Infect Dis
; 20(1): 799, 2020 Oct 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33115427
12.
Quantitative Results of a National Intervention to Prevent Clostridioides difficile Infection: A Pre-Post Observational Study.
Ann Intern Med
; 171(7_Suppl): S52-S58, 2019 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31569233
13.
A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile-associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation.
Clin Infect Dis
; 68(2): 196-203, 2019 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29893798
14.
Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: Guidelines from the American Society of Transplantation Community of Practice.
Clin Transplant
; 33(9): e13564, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31002420
15.
Performance of laboratory tests for detection for Clostridioides difficile: A multicenter prospective study in Japan.
Anaerobe
; 60: 102107, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31647977
16.
Clostridioides (Clostridium) difficile infection burden in Japan: A multicenter prospective study.
Anaerobe
; 60: 102011, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30872073
17.
Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660-A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection.
Clin Infect Dis
; 67(8): 1198-1204, 2018 09 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29617739
18.
Cost-effectiveness of Bezlotoxumab Compared With Placebo for the Prevention of Recurrent Clostridium difficile Infection.
Clin Infect Dis
; 66(3): 355-362, 2018 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-29106516
19.
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).
Clin Infect Dis
; 66(7): 987-994, 2018 03 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29562266
20.
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence.
Clin Infect Dis
; 67(5): 649-656, 2018 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-29538686